Cognetivity Neurosciences(CGNSF)
$0.000.00 (0.00%)
CGNSF
Cognetivity Neurosciences financials statements
$0.00
At close:0.00 (0.00%)
Cognetivity Neurosciences (CGNSF) Ratios
22 Followers
Cognetivity Neurosciences Ratios
CGNSF's free cash flow for Q3 2023 was C$-1.69K. For the 2023 fiscal year, CGNSF's free cash flow was decreased by C$-18.62K and operating cash flow was C$16.93K. See a summary of the company’s cash flow.
| Ratios | Apr 22 | Apr 21 | Apr 20 | Jan 20 | Jan 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.25 | 0.33 | 1.81 | 0.70 | 2.91 |
| Quick Ratio | 0.25 | 0.33 | 1.81 | 0.70 | 2.91 |
| Cash Ratio | 0.21 | 0.25 | 1.41 | 0.57 | 1.06 |
| Solvency Ratio | -0.58 | -1.71 | -1.99 | -2.61 | -17.68 |
| Operating Cash Flow Ratio | -0.56 | -0.58 | -2.03 | -1.84 | -14.73 |
| Short-Term Operating Cash Flow Coverage | -4.60 | -2.48 | -6.24 | -6.05 | 0.00 |
| Net Current Asset Value | C$ -10.06M | C$ -5.82M | C$ 786.32K | C$ -300.08K | C$ 453.46K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.46 | 0.65 | 0.17 | 0.41 | 0.00 |
| Debt-to-Equity Ratio | -0.13 | -0.23 | 0.36 | -1.17 | 0.00 |
| Debt-to-Capital Ratio | -0.15 | -0.30 | 0.27 | 6.98 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.29 | -0.35 | 2.12 | -2.84 | 1.49 |
| Debt Service Coverage Ratio | -2.75 | -9.60 | -6.36 | -7.11 | 0.00 |
| Interest Coverage Ratio | -6.12 | -215.30 | -38.09 | -46.54 | 0.00 |
| Debt to Market Cap | 0.06 | 0.04 | 0.01 | 0.03 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | 0.15 | 0.01 | 0.44 | 0.10 | 0.06 |
| Profitability Margins | |||||
| Gross Profit Margin | -4694.86% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -14121.44% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -14067.14% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -13866.36% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -16386.31% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -16386.31% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -16386.31% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.12% | 99.43% | 100.00% |
| EBT Per EBIT | 118.17% | 100.70% | 80.47% | 102.13% | 99.52% |
| Return on Assets (ROA) | -262.73% | -654.79% | -105.49% | -353.59% | -585.30% |
| Return on Equity (ROE) | 75.17% | 231.30% | -223.44% | 1005.61% | -874.54% |
| Return on Capital Employed (ROCE) | 81.02% | 367.19% | -277.35% | 990.29% | -878.73% |
| Return on Invested Capital (ROIC) | 97.17% | 577.92% | -203.41% | -5889.85% | -874.16% |
| Return on Tangible Assets | -273.35% | -683.89% | -107.38% | -353.59% | -585.30% |
| Earnings Yield | -35.82% | -39.70% | -5.75% | -30.07% | -25.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.03 | 0.03 | 0.02 | 0.01 | 0.02 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 2628.36 | -12684.56 | -20319.19 | -24710.88 | -20167.59 |
| Days of Sales Outstanding | 2983.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 355.39 | 12684.56 | 20319.19 | 24710.88 | 20167.59 |
| Operating Cycle | 2983.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.07 | -0.04 | -0.03 | -0.04 | -0.09 |
| Free Cash Flow Per Share | -0.07 | -0.05 | -0.03 | -0.04 | -0.09 |
| Dividend Paid and CapEx Coverage Ratio | -85.27 | -32.14 | -39.11 | -85.08 | -165.30 |
| Capital Expenditure Coverage Ratio | -85.27 | -32.14 | -39.11 | -85.08 | -165.30 |
| Operating Cash Flow Coverage Ratio | -4.60 | -2.48 | -6.24 | -6.05 | 0.00 |
| Operating Cash Flow to Sales Ratio | -130.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -28.97% | -10.03% | -5.99% | -21.35% | -21.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.79 | -2.52 | -17.38 | -3.33 | -3.92 |
| Price-to-Sales (P/S) Ratio | 457.42 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -2.10 | -5.83 | 38.83 | -33.45 | 34.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.45 | -9.97 | -16.68 | -4.68 | -4.68 |
| Price-to-Operating Cash Flow Ratio | -3.49 | -10.29 | -17.11 | -4.74 | -4.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -0.01 | 0.40 | 0.08 | -0.02 |
| Enterprise Value Multiple | -3.10 | -2.53 | -13.56 | -3.29 | -3.85 |
| Enterprise Value | 19.80M | 32.98M | 32.46M | 8.53M | 16.19M |
| EV to EBITDA | -3.10 | -2.53 | -13.56 | -3.29 | -3.85 |
| EV to Sales | 436.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.29 | -9.95 | -16.16 | -4.54 | -4.61 |
| EV to Operating Cash Flow | -3.33 | -10.26 | -16.57 | -4.59 | -4.64 |
| Tangible Book Value Per Share | -0.12 | -0.08 | 0.01 | -0.01 | 0.01 |
| Shareholders’ Equity Per Share | -0.12 | -0.08 | 0.01 | -0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.01 | 0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.09 | -0.18 | -0.03 | -0.06 | -0.10 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.16 | 1.01 | 0.80 | 1.05 | 1.02 |
| Research & Development to Revenue | 13.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 111.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 12.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | 0.24 | 1.02 | 0.70 | 0.83 |
Currency in CAD

